Drug Policy Transformed?

I’ve spent the morning looking over the Transform Drug Policy Foundation’s consultation paper, A Comparison of the Cost-Effectiveness of the Prohibition and Regulation of Drugs, which was published today.  The full report is available as a .pdf here (note the filesize – at 445k, it’s HUGE) – or there’s a summary on Transform’s blog, here. […]

Read More…

A Big Week for Little Cells

Stem cells have been in the news rather a lot lately.  President Obama has, it’s currently being widely reported, lifted Dubya’s restrictions on human embryonic stem-cell research, much to the chagrin of some, and the delight of others.  (Interestingly enough, among the worriers we find a surprisingly large number of British commentators who point out […]

Read More…

Drugs are Bad, m’kaaaay?

As widely predicted, the Advisory Council on the Misuse of Drugs has advised that ecstasy be downgraded from a class-A to a class-B drug.  This comes in the wake of the Council’s chair, David Nutt, suggesting that ecstasy ought to be considered no more dangerous than horse-riding.  (The full article can be found here, but for non-institutional readers, a […]

Read More…

Barbados, HIV and Nursing Policy

There is a controversy brewing in Barbados concerning Nigerian nurses and HIV – in particular, concerning the way the story was reported by the CBC, which provoked industrial action. As Alison Mayers points out in a (fairly impassioned) guest column in The Nation, there are many things that we might ask about HIV and the use of Nigerian […]

Read More…